Correlation Between Icecure Medical and NanoVibronix

Can any of the company-specific risk be diversified away by investing in both Icecure Medical and NanoVibronix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Icecure Medical and NanoVibronix into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Icecure Medical and NanoVibronix, you can compare the effects of market volatilities on Icecure Medical and NanoVibronix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Icecure Medical with a short position of NanoVibronix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Icecure Medical and NanoVibronix.

Diversification Opportunities for Icecure Medical and NanoVibronix

0.12

Correlation Coefficient

Icecure Medical  NanoVibronix

Average diversification

The 3 months correlation between Icecure and NanoVibronix is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Icecure Medical and NanoVibronix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NanoVibronix and Icecure Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Icecure Medical are associated (or correlated) with NanoVibronix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NanoVibronix has no effect on the direction of Icecure Medical i.e., Icecure Medical and NanoVibronix go up and down completely randomly.

Pair Corralation between Icecure Medical and NanoVibronix

Given the investment horizon of 90 days Icecure Medical is expected to generate 1.02 times more return on investment than NanoVibronix. However, Icecure Medical is 1.02 times more volatile than NanoVibronix. It trades about 0.19 of its potential returns per unit of risk. NanoVibronix is currently generating about 0.01 per unit of risk. If you would invest  61.00  in Icecure Medical on September 30, 2024 and sell it today you would earn a total of  51.00  from holding Icecure Medical or generate 83.61% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Icecure Medical  vs.  NanoVibronix

Icecure Medical

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Icecure Medical are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile fundamental indicators, Icecure Medical displayed solid returns over the last few months and may actually be approaching a breakup point.

NanoVibronix

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in NanoVibronix are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, NanoVibronix is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Icecure Medical and NanoVibronix

The main advantage of trading using opposite Icecure Medical and NanoVibronix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Icecure Medical position performs unexpectedly, NanoVibronix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NanoVibronix will offset losses from the drop in NanoVibronix's long position.

The idea behind Icecure Medical and NanoVibronix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.